There’s a new treatment option for some patients with pancreatic cancer -- those who carry a specific genetic mutation can now be treated with the drug olaparib.
types, whereas there are few options for pancreatic cancer. It’s one of the most devastating cancers -- survival rates are the lowest of the most common cancer types. patients have been waiting a long time for new therapy options for their devastating disease," said Julie Fleshman, president and CEO of Pancreatic Cancer Action Network, a patient support group.
"Today's approval of olaparib provides an exciting new treatment option for patients with germline BRCA-mutated metastatic pancreatic cancer," she said in a statement. About 4% to 9% of people who have metastatic pancreatic cancer are thought to carry the BRCA mutation.
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
FDA to Ban All E-Cigarette Pod Flavors Except Tobacco and MentholThe FDA plans to ban the sale of fruity flavors in cartridge-based e-cigarettes, but the restriction won’t apply to tank vaping systems commonly found at vape shops.
Read more »
New FDA labels include nutrition info for eating that whole bag of chips or pint of ice creamNew guidelines require two side-by-side columns: one with nutritional information for a single serving, and a second with information for eating the entire package.
Read more »
New FDA labels include nutrition info for eating that whole bag of chips or pint of ice creamOn Jan. 1, the Food and Drug Administration's new nutrition labeling rules kick in, ushering in a host of changes to the way that manufacturers are required to label packaged foods. Perhaps most notably, new guidelines require two side-by-side columns: one with nutritional information for a single
Read more »